Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders
Judge Determines Johnson & Johnson Should Be Required to Pay $6.8M in Punitive Damage For Failing to Warn About Risperdal Risks
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Breast Cancer Side Effects Linked to Antipsychotic Medications: Study Those antipsychotics which caused higher levels of prolactin, like Risperdal, had a stronger link to breast cancer risks December 9, 2021 Irvin Jackson Add Your Comments The findings of a new study suggest that side effects of antipsychotic medications may increase the risk of breast cancer by as much as 35%, with some particular drugs, such as Risperdal, Haldol, and Invega, causing even greater impact. Researchers with the Washington University School of Medicine in St. Louis found a link between the antipsychotic drugs and how they affect the hormone prolactin, which they say can significantly increase the chance of breast cancer for women. Those drugs which generated the highest levels of prolactin, known as Category 1 antipsychotics, were linked to the largest increased breast cancer side effects. Their findings were published online in the Journal of Clinical Psychopharmacology on December 3, and will appear in print in the February 2022 issue. The researchers used IBM MarketScan Commercial and Medicaid Databases, comparing women taking antipsychotics to those taking anticonvulsants or lithium. Out of data involving more than 540,000 women, a total of 914 cases of invasive breast cancer were identified. According to their findings, exposure to any antipsychotic was associated with a 35% increased risk of breast cancer. However, Category 1 drugs, like Risperdal and Sustenna, which resulted in high prolactin levels, were linked to a 62% increased risk. Category 2 drugs, like Fanapt, Latuda and Zyprexa, were associated with a 54% increased risk of breast cancer, while Category 3 antipsychotics did not appear to increase the risk of a breast cancer diagnosis at all. Learn More About Risperdal Lawsuits Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Risperdal Lawsuits Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “Many women with psychiatric illnesses such as schizophrenia and bipolar disorder will take antipsychotics for decades, and they are essential to keeping symptoms in check,” lead author Tahir Rahman, an associated professor of psychiatry, said in a Washington University press release. “But both older antipsychotic medicines and some newer drugs raise levels of prolactin and increase the risk of breast cancer, which is concerning. Our study confirms findings from a smaller European study that advised women and their doctors to first try drugs that don’t affect prolactin levels. We agree with that advice and believe psychiatrists should start to monitor prolactin levels in their patients taking antipsychotics.” In August, Finnish researchers published a study in The Lancet, which found a strong relationship between the use of prolactin-increasing antipsychotics and the development of lobular adenocarcinoma; a form of breast cancer. While antipsychotics have become increasingly popular, past studies have shown antipsychotic drugs have serious potential side effects, including reduced alertness, decreased blood pressure, increased risk of diabetes and heart disease, and even movement disorders that resemble those seen in Parkinson’s. In January 2019, a study published in the medical journal JAMA Psychiatry, found children and young adults taking antipsychotic faced an increased risk of sudden death from cardiovascular or metabolic causes. A 2016 study published in the May issue of JAMA Neurology found the mortality rates of patients with Parkinson’s disease who took antipsychotics were much higher compared with matched patients. The study highlighted the risks many nursing home residents face from being given antipsychotics as a form of chemical restraint. More Risperdal Lawsuit Stories Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022 $70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review May 18, 2021 Judge Determines Johnson & Johnson Should Be Required to Pay $6.8M in Punitive Damage For Failing to Warn About Risperdal Risks January 20, 2020 1 Comments Donna April 21, 2023 I was force injected Risperdal for 2 years before breast cancer. I asked my psychiatrist for a blood prolactin level test. Sure enough it was 3x the normal limit. They now claim that paliperidol ( invega) also a Category 1 antipsychotic is harmless for prolactin if given with aripiprazole (abilify) Do I suddenly start believing people who failed already to inform me of dangerous side effects? Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025) Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025) Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022
$70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review May 18, 2021
Judge Determines Johnson & Johnson Should Be Required to Pay $6.8M in Punitive Damage For Failing to Warn About Risperdal Risks January 20, 2020
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)
Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)